LPL Financial LLC Sells 1,061 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LPL Financial LLC trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 9.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,306 shares of the medical instruments supplier’s stock after selling 1,061 shares during the quarter. LPL Financial LLC’s holdings in LeMaitre Vascular were worth $950,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of LMAT. Copeland Capital Management LLC raised its stake in LeMaitre Vascular by 0.7% during the 4th quarter. Copeland Capital Management LLC now owns 1,172,015 shares of the medical instruments supplier’s stock valued at $107,990,000 after purchasing an additional 8,623 shares during the last quarter. Congress Asset Management Co. raised its position in shares of LeMaitre Vascular by 1.8% during the fourth quarter. Congress Asset Management Co. now owns 722,325 shares of the medical instruments supplier’s stock valued at $66,555,000 after buying an additional 13,009 shares during the last quarter. Geode Capital Management LLC raised its position in shares of LeMaitre Vascular by 4.5% during the third quarter. Geode Capital Management LLC now owns 542,523 shares of the medical instruments supplier’s stock valued at $50,403,000 after buying an additional 23,443 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of LeMaitre Vascular by 2.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 195,752 shares of the medical instruments supplier’s stock valued at $18,037,000 after buying an additional 4,241 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in LeMaitre Vascular during the fourth quarter worth about $14,900,000. 84.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Wells Fargo & Company started coverage on LeMaitre Vascular in a report on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 price target for the company. Barrington Research cut LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Lake Street Capital increased their price objective on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, Oppenheimer cut shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.25.

LeMaitre Vascular Price Performance

LMAT stock opened at $86.28 on Monday. The stock has a market capitalization of $1.95 billion, a price-to-earnings ratio of 47.15, a P/E/G ratio of 2.22 and a beta of 0.89. LeMaitre Vascular, Inc. has a fifty-two week low of $62.40 and a fifty-two week high of $109.58. The business has a fifty day moving average price of $87.85 and a 200 day moving average price of $93.52.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The firm had revenue of $55.81 million during the quarter, compared to analysts’ expectations of $55.99 million. On average, equities analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 27th. Stockholders of record on Thursday, March 13th were paid a $0.20 dividend. The ex-dividend date of this dividend was Thursday, March 13th. This is a boost from LeMaitre Vascular’s previous quarterly dividend of $0.16. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.93%. LeMaitre Vascular’s dividend payout ratio is 41.24%.

Insider Activity at LeMaitre Vascular

In other news, insider Trent G. Kamke sold 2,009 shares of LeMaitre Vascular stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $82.12, for a total transaction of $164,979.08. Following the transaction, the insider now directly owns 5,564 shares of the company’s stock, valued at $456,915.68. This trade represents a 26.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 10.79% of the stock is currently owned by corporate insiders.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.